MCP
LEGN icon

Maso Capital Partners’s Legend Biotech LEGN Stock Holding History

Maso Capital Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,000
Closed -$814K – 38
2024
Q4 		$814K Hold
25,000
– – 1.03% 14
2024
Q3 		$1.22M Buy
+25,000
New +$1.33M 1.14% 15

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Maso Capital Partners's LEGN Position: Q1 2025 in Review

Maso Capital Partners sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 25,000 shares — an estimated $814K sold.

Maso Capital Partners first reported a position in LEGN in Q3 2024 and held it in 2 quarters. The position peaked at $1.22M in Q3 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Maso Capital Partners reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Maso Capital Partners sold 25,000 Legend Biotech shares in Q1 2025, an estimated $814K.
  • Maso Capital Partners first reported a position in Legend Biotech in Q3 2024 and held it in 2 quarters.
  • Maso Capital Partners's Legend Biotech position peaked at $1.22M in Q3 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Maso Capital Partners's 13F filing for Q1 2025, filed 9 May 2025.